DOCSLIB.ORG

Guideline on Lichen Sclerosus

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Guideline on Lichen Sclerosus Guideline on Lichen sclerosus Developed by the Guideline Subcommittee of the European Dermatology Forum Subcommittee Members: Dr. Gudula Kirtschig, Nottingham (United Kingdom) Dr. Silke Riechardt, Hamburg (Germany) Dr. Karl Becker, Bonn (Germany) Dr. Francesco Casabona, Genova (Italy) PD Dr. Andreas Günthert, Lucerne (Switzerland) Dr. Jenny Powell, Hampshire (United Kingdom) Dr. Daiva Jasaitienè, Panevezys (Lithuania) Fabia Brackenbury (United Kingdom) Dr. Susan Cooper, Oxford (United Kingdom) Ricardo Erdmann, Berlin (Germany) Dr. Ching-Chi Chi, Taoyuan (Taiwan) Dr. Massimo Lazzeri, Arezzo (Italy) Prof. Alexander Kreuter, Oberhausen (Germany) Prof. Dr. Guido Barbagli, Arezzo (Italy) Dr. Kristin Katharina Rall, Tübingen (Germany) Prof. Dr. Fenella Wojnarowska, Oxford (United Kingdom) Prof. Dr. Werner Aberer, Graz (Austria) Members of EDF Guideline Committee: Prof. Dr. Werner Aberer, Graz (Austria) Prof. Dr. Dieter Metze, Muenster (Germany) Prof. Dr. Martine Bagot, Paris (France) Prof. Dr. Gillian Murphy, Dublin (Ireland) Prof. Dr. Nicole Basset-Seguin, Paris (France) PD Dr. Alexander Nast, Berlin (Germany) Prof. Dr. Ulrike Blume-Peytavi, Berlin (Germany) Prof. Dr. Martino Neumann, Rotterdam (Netherlands) Prof. Dr. Lasse Braathen, Bern (Switzerland) Prof. Dr. Tony Ormerod, Aberdeen (United Kingdom) Prof. Dr. Sergio Chimenti, Rome (Italy) Prof. Dr. Mauro Picardo, Rome (Italy) Prof. Dr. Alexander Enk, Heidelberg (Germany) Prof. Dr. Annamari Ranki, Helsinki (Finland) Prof. Dr. Claudio Feliciani, Rome (Italy) Prof. Dr. Johannes Ring, Munich (Germany) Prof. Dr. Claus Garbe, Tuebingen (Germany) Prof. Dr. Berthold Rzany, Berlin (Germany) Prof. Dr. Harald Gollnick, Magdeburg (Germany) Prof. Dr. Rudolf Stadler, Minden (Germany) Prof. Dr. Gerd Gross, Rostock (Germany) Prof. Dr. Sonja Ständer, Muenster (Germany) Prof. Dr. Vladimir Hegyi, Bratislava (Slovakia) Prof. Dr. Wolfram Sterry, Berlin (Germany) Prof. Dr. Michael Hertl, Marburg (Germany) Prof. Dr. Eggert Stockfleth, Berlin (Germany) Prof. Dr. Dimitrios Ioannides, Thessaloniki (Greece) Prof. Dr. Alain Taieb, Bordeaux (France) Prof. Dr. Gregor Jemec, Roskilde (Denmark) Prof. Dr. George-Sorin Tiplica, Bucharest (Romania) Prof. Dr. Lajos Kemény, Szeged (Hungary) Prof. Dr. Nikolai Tsankov, Sofia (Bulgaria) Dr. Gudula Kirtschig, Amsterdam (Netherlands) Prof. Dr. Elke Weisshaar, Heidelberg (Germany) Prof. Dr. Robert Knobler, Vienna (Austria) Prof. Dr. Sean Whittaker, London (United Kingdom) Prof. Dr. Annegret Kuhn, Muenster (Germany) Prof. Dr. Fenella Wojnarowska, Oxford (United Kingdom) Prof. Dr. Marcus Maurer, Berlin (Germany) Prof. Dr. Christos Zouboulis, Dessau (Germany) Prof. Dr. Kai Munte, Rotterdam (Netherlands) Prof. Dr. Torsten Zuberbier, Berlin (Germany) Chairman of EDF Guideline Committee: PD Dr. Alexander Nast, Berlin (Germany) Expiry date: 09/2017 EDF Guidelines Secretariat to PD Dr. Alexander Nast: Bettina Schulze, Klinik für Dermatologie, Venerologie und Allergologie, Campus Charité Mitte, Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany phone: ++49 30 450 518 062, fax: ++49 30 450 518 911, e-mail: bettina.schulze@charité.de Conflicts of interests The Work Under Consideration for Publication Katharina Rall Werner Aberer Gudula Kirtschig Sue Cooper 1 Grant no no no no 2 Consulting fee or no no no no honorarium 3 Support for travel to no no no no meetings for the study or other purposes 4 Fees for participation in no no no no review activities, such as data monitoring boards, statistical analysis, end point committees, and the like 5 Payment for writing or no no no no reviewing the manuscript 6 Provision of writing no no no no assistance, medicines, equipment, or administrative support 7 Other no no no no * This means money that your institution received for your efforts on this study. Relevant financial activities outside the submitted work 1 Board membership no no no no 2 Consultancy no no no no 3 Employment no no no no 4 Expert testimony no no no no 5 Grants/grants pending no no no no 6 Payment for lectures no no no no including service on speakers bureaus 7 Payment for no no no no manuscript preparation 8 Patents (planned, no no no no pending or issued) 9 Royalties no no no no 10 Payment for no no no no development of educational presentations 11 Stock/stock options no no no no 12 Travel/accommodation no no no no s/meeting expenses unrelated to activities listed** 13 Other (err on the side no no no no of full disclosure) * This means money that your institution received for your efforts. ** For example, if you report a consultancy above there is no need to report travel related to that consultancy on this line. Other relationships 1 Are there other no no no no relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work? Conflicts of interests 2 The Work Under Consideration for Publication Fabia Brackenbury Ching-Chi Chi Jenny Powell G Barbagli 1 Grant no no no no 2 Consulting fee or no no no no honorarium 3 Support for travel to no no no no meetings for the study or other purposes 4 Fees for participation in no no no no review activities, such as data monitoring boards, statistical analysis, end point committees, and the like 5 Payment for writing or no no no no reviewing the manuscript 6 Provision of writing no no no no assistance, medicines, equipment, or administrative support 7 Other no no no no * This means money that your institution received for your efforts on this study. Relevant financial activities outside the submitted work 1 Board membership no no no no 2 Consultancy no no no no 3 Employment no no no no 4 Expert testimony no no no no 5 Grants/grants pending no no no no 6 Payment for lectures no no no no including service on speakers bureaus 7 Payment for no no no no manuscript preparation 8 Patents (planned, no no no no pending or issued) 9 Royalties no no no no 10 Payment for no no no no development of educational presentations 11 Stock/stock options no no no no 12 Travel/accommodation no no no no s/meeting expenses unrelated to activities listed** 13 Other (err on the side no no no no of full disclosure) * This means money that your institution received for your efforts. ** For example, if you report a consultancy above there is no need to report travel related to that consultancy on this line. Other relationships 1 Are there other no no no no relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work? Conflicts of interests 3 The Work Under Consideration for Publication A Kreuter R Erdmann M Lazzeri F Casabona 1 Grant no European no no Dermatology Forum 2 Consulting fee or Referentenhon no no no honorarium orare von MEDA Pharma 3 Support for travel to no no no no meetings for the study or other purposes 4 Fees for participation no no no no in review activities, such as data monitoring boards, statistical analysis, end point committees, and the like 5 Payment for writing no no no no or reviewing the manuscript 6 Provision of writing no no no no assistance, medicines, equipment, or administrative support 7 Other Advisory-board no no no Aktivität für Sanofi Pasteur MSD und Biotest * This means money that your institution received for your efforts on this study. Relevant financial activities outside the submitted work 1 Board membership no no no no 2 Consultancy no no no no 3 Employment no no no no 4 Expert testimony no no no no 5 Grants/grants Galderma pending Laboratorium GmbH, Ipsen Pharma GmbH, Kythera Biopharmaceu- ticals, European Dermatology Forum (EDF), Deutsche Dermatologische Gesellschaft (DDG), Deutsche Forschungsgeme inschaft (DFG), Paul-Ehrlich- Gesellschaft für Chemotherapie e.V., Deutsche Gesellschaft für Radioonkologie e.V. sowie GlaxoSmithKline Ltd. 6 Payment for lectures no no no no including service on speakers bureaus 7 Payment for no no no no manuscript preparation 8 Patents (planned, no no no no pending or issued) 9 Royalties no no no no 10 Payment for no no no no development of educational presentations 11 Stock/stock options no no no no 12 Travel/accommodati no no no no ons/meeting expenses unrelated to activities listed** 13 Other (err on the no no no no side of full disclosure) * This means money that your institution received for your efforts. ** For example, if you report a consultancy above there is no need to report travel related to that consultancy on this line. Other relationships 1 Are there other no no no no relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work? Conflicts of interests The Work Under Consideration for Publication S Riechardt F Wojnarowska Karl Becker D Jasaitiene 1 Grant no no no no 2 Consulting fee or no honorarium for no no honorarium speaking at vulval study day, 2012 3 Support for travel to no no no no meetings for the study or other purposes 4 Fees for participation in no no no no review activities, such as data monitoring boards, statistical analysis, end point committees, and the like 5 Payment for writing or no no no no reviewing the manuscript 6 Provision of writing no no no no assistance, medicines, equipment, or administrative support 7 Other no no no no * This means money that your institution received for your efforts on this study. Relevant financial activities outside the submitted work 1 Board membership no no no no 2 Consultancy no no no no 3 Employment no no no no 4 Expert testimony no no no no 5 Grants/grants pending no no no no 6 Payment for lectures no no no no including service on speakers bureaus 7 Payment for no no no no manuscript preparation 8 Patents (planned, no no no no pending or issued) 9 Royalties no no no no 10 Payment for no no no no development of educational presentations 11 Stock/stock options no no no no 12 Travel/accommodation no no no no s/meeting expenses unrelated to activities listed** 13 Other (err on the side no no no no of full disclosure) * This means money that your institution received for your efforts.
Load more

Recommended publications
  • Diagnosing and Managing Vulvar Disease
    Diagnosing and Managing Vulvar Disease John J. Willems, M.D. FRCSC, FACOG Chairman, Department of Obstetrics & Gynecology Scripps Clinic La Jolla, California Objectives: IdentifyIdentify thethe majormajor formsforms ofof vulvarvulvar pathologypathology DescribeDescribe thethe appropriateappropriate setupsetup forfor vulvarvulvar biopsybiopsy DescribeDescribe thethe mostmost appropriateappropriate managementmanagement forfor commonlycommonly seenseen vulvarvulvar conditionsconditions Faculty Disclosure Unlabeled Product Company Nature of Affiliation Usage Warner Chilcott Speakers Bureau None ClassificationClassification ofof VulvarVulvar DiseaseDisease byby ClinicalClinical CharacteristicCharacteristic • Red lesions • White lesions • Dark lesions •Ulcers • Small tumors • Large tumors RedRed LesionsLesions • Candida •Tinea • Reactive vulvitis • Seborrheic dermatitis • Psoriasis • Vulvar vestibulitis • Paget’s disease Candidal vulvitis Superficial grayish-white film is often present Thick film of candida gives pseudo-ulcerative appearance. Acute vulvitis from coital trauma Contact irritation from synthetic fabrics Nomenclature SubtypesSubtypes ofof VulvodyniaVulvodynia:: VulvarVulvar VestibulitisVestibulitis SyndromeSyndrome (VVS)(VVS) alsoalso knownknown asas:: • Vestibulodynia • localized vulvar dysesthesia DysestheticDysesthetic VulvodyniaVulvodynia alsoalso knownknown asas:: • “essential” vulvodynia • generalized vulvar dysesthesia Dysesthesia Unpleasant,Unpleasant, abnormalabnormal sensationsensation examplesexamples include:include:
    [Show full text]
  • An International Urogynecological Association (IUGA)
    Received: 18 December 2017 | Accepted: 18 December 2017 DOI: 10.1002/nau.23508 TERMINOLOGY An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the assessment of sexual health of women with pelvic floor dysfunction Rebecca G. Rogers MD1 | Rachel N. Pauls MD2 | Ranee Thakar MD3 | Melanie Morin PhD4 | Annette Kuhn MD5 | Eckhard Petri Dd, PhD6 | Brigitte Fatton MD7 | Kristene Whitmore MD8 | Sheryl Kinsberg PhD9 | Joseph Lee MBChB, FRANZCOG10 1 Dell Medical School, University of Texas, Austin, Texas 2 TriHealth Good Samaritan Hospital, Cincinnati, Ohio 3 Croydon University Hospital Croydon, London, United Kingdom 4 Universite de Sherbrooke, Montreal, Quebec, Canada 5 University Teaching Hospital Berne (Inselspital), Bern, Switzerland 6 University of Greifswald, Schwerin, Germany 7 University Hospital Nîmes, Nimes, Languedoc-Roussillon, France 8 Drexel University College of Medicine, Philadelphia, Pennsylvania 9 Case Western Reserve University, Cleveland, Ohio 10 University of New South Wales, St Vincents Hospital, Sydney, New South Wales, Australia Correspondence Aims: The terminology in current use for sexual function and dysfunction in women Rebecca G. Rogers, Department of Women's Health, 1301 W 38th Street, with pelvic floor disorders lacks uniformity, which leads to uncertainty, confusion, Suit705, Dell Medical School, University and unintended ambiguity. The terminology for the sexual health of women with of Texas, Austin, TX 78705. pelvic floor dysfunction needs to be collated in a clinically-based consensus report. Email: [email protected] Methods: This report combines the input of members of the Standardization and Terminology Committees of two International Organizations, the International Urogynecological Association (IUGA), and the International Continence Society (ICS), assisted at intervals by many external referees.
    [Show full text]
  • Current Uses of Surgery in the Treatment of Genital Pain Michelle King, Rachel Rubin & Andrew T. Goldstein
    Current Uses of Surgery in the Treatment of Genital Pain Michelle King, Rachel Rubin & Andrew T. Goldstein Current Sexual Health Reports ISSN 1548-3584 Curr Sex Health Rep DOI 10.1007/s11930-014-0032-8 1 23 Your article is protected by copyright and all rights are held exclusively by Springer Science+Business Media, LLC. This e-offprint is for personal use only and shall not be self- archived in electronic repositories. If you wish to self-archive your article, please use the accepted manuscript version for posting on your own website. You may further deposit the accepted manuscript version in any repository, provided it is only made publicly available 12 months after official publication or later and provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com”. 1 23 Author's personal copy Curr Sex Health Rep DOI 10.1007/s11930-014-0032-8 FEMALE SEXUAL DYSFUNCTION AND DISORDERS (A GIRALDI AND L BROTTO, SECTION EDITORS) Current Uses of Surgery in the Treatment of Genital Pain Michelle King & Rachel Rubin & Andrew T. Goldstein # Springer Science+Business Media, LLC 2014 Abstract Genital pain frequently causes sexual dysfunction during sexual intercourse, vary greatly. However, it has and psychological distress that can impact every aspect of a been suggested that as many as 17–19 % of women woman’s life. When conservative medical treatments do not have a lifetime prevalence of dyspareunia [1].
    [Show full text]
  • Joint Report on Terminology for Surgical Procedures to Treat Pelvic
    AUGS-IUGA JOINT PUBLICATION Joint Report on Terminology for Surgical Procedures to Treat Pelvic Organ Prolapse Developed by the Joint Writing Group of the American Urogynecologic Society and the International Urogynecological Association. Individual contributors are noted in the acknowledgment section. 03/02/2020 on BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3JfJeJsayAVVC6IBQr6djgLHr3m8XRMZF6k61FXizrL9aj3Mm1iL7ZA== by https://journals.lww.com/jpelvicsurgery from Downloaded meaningful data about specific procedures, standardized and Downloaded Abstract: Surgeries for pelvic organ prolapse (POP) are common, but widely accepted terminology must be adopted. Each term for a standardization of surgical terms is needed to improve the quality of in- given procedure must indicate to researchers, clinicians, and from vestigation and clinical care around these procedures. The American learners a specific and reliable minimal set of steps. The aim of https://journals.lww.com/jpelvicsurgery Urogynecologic Society and the International Urogynecologic Associ- this document is to propose a standardized terminology to de- ation convened a joint writing group consisting of 5 designees from scribe common surgeries for POP. each society to standardize terminology around common surgical terms in POP repair including the following: sacrocolpopexy (including sacral colpoperineopexy), sacrocervicopexy, uterosacral ligament suspension, sacrospinous ligament fixation, iliococcygeus fixation, uterine preserva- tion prolapse procedures or hysteropexy
    [Show full text]
  • Female Genital Cosmetic Surgery: a Review of Techniques and Outcomes
    Int Urogynecol J (2013) 24:1997–2009 DOI 10.1007/s00192-013-2117-8 REVIEW ARTICLE Female genital cosmetic surgery: a review of techniques and outcomes Cheryl B. Iglesia & Ladin Yurteri-Kaplan & Red Alinsod Received: 15 April 2013 /Accepted: 18 April 2013 /Published online: 22 May 2013 # The International Urogynecological Association 2013 Abstract The aesthetic and functional procedures that com- Keyword Female genital cosmetic surgery . Cosmetic prise female genital cosmetic surgery (FGCS) include tradi- gynecology . Vaginal rejuvenation . Labiaplasty . tional vaginal prolapse procedures as well as cosmetic Vaginoplasty vulvar and labial procedures. The line between cosmetic and medically indicated surgical procedures is blurred, and today many operations are performed for both purposes. The Introduction contributions of gynecologists and reconstructive pelvic surgeons are crucial in this debate. Aesthetic vaginal sur- Consumer marketing and media hype have spawned the con- geons may unintentionally blur legitimate female pelvic siderable controversy over female genital cosmetic surgery floor disorders with other aesthetic conditions. In the ab- (FGCS). FGCS articles first appeared in North American sence of quality outcome data, the value of FGCS in im- journals in 1978, and the first technical article appeared in proving sexual function remains uncertain. Women seeking 1984 [1, 2]. This review describes the techniques and outcome FGCS need to be educated about the range and variation of data of labiaplasty, vaginoplasty, and other cosmetic gyneco- labia widths and genital appearance, and should be evaluat- logical procedures. ed for true pelvic support disorders such as pelvic organ prolapse and stress urinary incontinence. Women seeking FGCS should also be screened for psychological conditions Female genital perceptions and should act autonomously without coercion from part- ners or surgeons with proprietary conflicts of interest.
    [Show full text]
  • Clinical and Ethical Perspectives of Medical Professionals Towards Female Genital Cosmetic Procedures
    Clinical Investigation / Araştırma DOI: 10.4274/tjod.galenos.2021.85282 Turk J Obstet Gynecol 2021;18:131-138 Clinical and ethical perspectives of medical professionals towards female genital cosmetic procedures Tıp uzmanlarının genital kozmetik müdahalelere klinik ve etik açıdan bakış açıları Gülin Feykan Yeğin1, Gökhan Kılıç1, Elçin İşlek Seçen1, İbrahim Buğra Bahadır1, Emre Erdem Taş2, Hüseyin Levent Keskin3, Ayşe Filiz Yavuz2 1Ankara City Hospital, Clinic of Gynecology and Obstetrics, Ankara, Turkey 2Yıldırım Beyazıt University Faculty of Medicine, Department of Gynecology and Obstetrics, Ankara, Turkey 3University of Health Sciences Turkey Faculty of Medicine, Department of Gynecology and Obstetrics, İstanbul, Turkey Abstract Objective: To evaluate the attitudes of medical students and professionals towards female genital cosmetic procedures (FGCPs) in terms of medical justification, applicability in practical life, ethical concerns, patient autonomy, and the clinical/social/psychological benefits-harms of these procedures. Materials and Methods: A semi-structured questionnaire providing information about the attitudes of medical students and specialists (n=623) towards FGCPs including G-spot amplification, clitoral hood reduction, vaginoplasty, labia majora augmentation/reduction, labia minora augmentation/reduction, hymenoplasty, laser procedures, vulvar/perianal bleaching, and liposculpture, was completed by a target population and evaluated statistically. Results: Participants stated that FGCPs could be performed only upon patient request and there could rarely be a medical indication for their performance (p<0.05). Nearly half (44.5%) of the participants regarded hymenoplasty as controversial in terms of ethical issues, and 44.6% of participants do so for G-spot amplification. Over half (54.5%) of the participants agreed on the positive effect of FGCPs on improving the quality of life, 55.4% on improving self-esteem, and 54.1% on improving sexual functions of women.
    [Show full text]
  • Cosmetic Procedures
    CLINICAL MEDICAL POLICY Policy Name: Cosmetic Procedures Policy Number: MP-082-MD-PA Responsible Department(s): Medical Management Provider Notice Date: 05/21/2021 Issue Date: 05/21/2021 Effective Date: 06/21/2021 Next Annual Review: 02/2022 Revision Date: 02/17/2021 Products: Gateway Health℠ Medicaid Application: All participating hospitals and providers Page Number(s): 1 of 21 DISCLAIMER Gateway Health℠ (Gateway) medical policy is intended to serve only as a general reference resource regarding coverage for the services described. This policy does not constitute medical advice and is not intended to govern or otherwise influence medical decisions. POLICY STATEMENT Gateway Health℠ does not provide coverage under the medical-surgical benefits of the Company’s Medicaid products for cosmetic procedures for adults. This policy is designed to address medical necessity guidelines that are appropriate for the majority of individuals with a particular disease, illness or condition. Each person’s unique clinical circumstances warrant individual consideration, based upon review of applicable medical records. (Current applicable Pennsylvania HealthChoices Agreement Section V. Program Requirements, B. Prior Authorization of Services, 1. General Prior Authorization Requirements.) DEFINITIONS Prior Authorization Review Panel A panel of representatives from within the PA Department of Human Services who have been assigned organizational responsibility for the review, approval and denial of all PH-MCO Prior Authorization policies and procedures. Cosmetic Services – Services and procedures that may be surgical or nonsurgical, performed primarily to reshape normal, healthy structures of the body in order to improve the patient's appearance and self- esteem. Physical Functional Impairment – A condition in which the normal or proper action of a body part is damaged.
    [Show full text]
  • Surgical Management of a Persistent Lichen Sclerosus Case and Reconstruction of Vulva with Free Rotation and V-Y Advancement Flaps
    Eastern Journal of Medicine 18 (2013) 145-149 Case Report Surgical management of a persistent lichen sclerosus case and reconstruction of vulva with free rotation and V-Y advancement flaps Cihangir Mutlu Ercana,*, Mufit Cemal Yenena, Murat Dedea, Mustafa Devecib, Mustafa Ulubaya, Ibrahim Alanbaya, Hakan Coksuera aDepartment of Obstetrics and Gynecology, Gulhane Military Medical Academy, Etlik, Ankara, Turkey bDepartment of Plastic and Reconstructive Surgery, Gülhane Military Medical Academy, Etlik, Ankara, Turkey Abstract. Lichen sclerosus (LS) is a lymphocyte-mediated, chronic, inflammatory dermatitis which most commonly involves the anogenital area. Treatment options include topical corticosteroids, tacrolimus, carbon dioxide laser ablation and, as a last resort vulvectomy. The objective of this study is to report a refractory anogenital LS case and describe the use of a V-Y advancement flap for reconstruction of the perineal defect after vulvectomy. A case of persistent LS, treated succesfully with surgery is presented and the literature is reviewed. The patient tolerated the surgical procedure well and a satisfactory cosmetic result was obtained. A multidisciplinary team is ideal in the management of patients with persistent LS. Surgical management of LS should be reserved as a last resort for patients who are refractory to other medical treatment options and, in the case of a surgical attempt, techniques for reconstruction of the vulva should be well known. Key words: Lichen sclerosus, vulvectomy, vulvar reconstruction Classic LS is characterized by marked 1. Introduction inflammation, epithelial thinning and distinctive Lichen sclerosus (LS) is a benign, chronic skin dermal changes with the appearance of fine disease that most commonly occurs in the "cigarette paper-like” wrinkling accompanied by anogenital epithelium (1).
    [Show full text]
  • Joint Report on Terminology for Surgical Procedures to Treat Pelvic Organ Prolapse
    International Urogynecology Journal https://doi.org/10.1007/s00192-020-04236-1 AUGS-IUGA JOINT PUBLICATION Joint report on terminology for surgical procedures to treat pelvic organ prolapse Developed by the Joint Writing Group of the American Urogynecologic Society and the International Urogynecological Association # American Urogynecologic Society and International Urogynecological Association 2020 Abstract Surgeries for pelvic organ prolapse (POP) are common, but standardization of surgical terms is needed to improve the quality of investigation and clinical care around these procedures. The American Urogynecologic Society and the International Urogynecologic Association convened a joint writing group consisting of 5 designees from each society to standardize terminology around common surgical terms in POP repair including the following: sacrocolpopexy (including sacral colpoperineopexy), sacrocervicopexy, uterosacral ligament suspension, sacrospinous ligament fixation, iliococcygeus fixation, uterine preservation prolapse procedures or hysteropexy (including sacrohysteropexy, uterosacral hysteropexy, sacrospinous hysteropexy, anterior abdominal wall hysteropexy, Manchester procedure), anterior prolapse procedures (including anterior vaginal repair, anterior vaginal repair with graft, and paravaginal repair), posterior prolapse procedures (including posterior vaginal repair, posterior vaginal repair with graft, levator plication, and perineal repair), and obliterative prolapse repairs (including colpocleisis with hysterectomy, colpocleisis
    [Show full text]
  • Posterior Vaginoplasty with Perineoplasty: a Canadian
    applyparastyle "fig//caption/p[1]" parastyle "FigCapt" applyparastyle "fig" parastyle "Figure" My Way Aesthetic Surgery Journal Open Forum Posterior Vaginoplasty With Perineoplasty: 2019, Vol 1 (4) 1–9 © 2019 The American Society for Aesthetic Plastic Surgery, Inc. A Canadian Experience With Vaginal This is an Open Access article dis- tributed under the terms of the Tightening Surgery Creative Commons Attribution License (http://creativecommons. org/licenses/by/4.0/), which permits unrestricted reuse, distri- bution, and reproduction in any medium, provided the original Ryan E. Austin, MD, FRCS(C) ; Frank Lista, MD, FRCS(C); work is properly cited. Peter-George Vastis; and Jamil Ahmad, MD, FRCS(C) DOI: 10.1093/asjof/ojz030 www.asjopenforum.com Abstract Following vaginal trauma, most commonly vaginal delivery, women may experience vaginal laxity as a result of local tissue stretching and separation of the pelvic floor musculature. In addition to this generalized sensation of laxity, women may complain of decreased sexual satisfaction, gaping of the perineum, and excessive vaginal secretions. Since 2014, the authors have used a posterior vaginoplasty with perineoplasty technique for the surgical management of vaginal laxity. To date, the authors have performed surgical vaginal tightening in 30 consecutive patients and found that the posterior vaginoplasty with perineoplasty technique has allowed us to achieve reproducible outcomes with no postoperative complications. This article will review the authors’ approach to patients presenting for surgical vaginal tightening and the authors’ experience to date, including our preoperative screening, perioperative management, and detailed steps of the procedure. Editorial Decision date: August 9, 2019; online publish-ahead-of-print October 15, 2019.
    [Show full text]
  • Research Update E- Newsletter December 2020 – January – February 2021 Vulvodynia Pharmacol
    Research Update E- Newsletter December 2020 – January – February 2021 www.nva.org _____________________ Vulvodynia Pharmacological modulation of voltage-gated sodium (NaV) channels alters nociception arising from the female reproductive tract Joel Castro, Jessica Maddern, Andelain Erickson, Ashlee Caldwell, Luke Grundy, Andrea M Harrington, Stuart M Brierley Pain. 2021 Jan;162(1):227-242. doi: 10.1097/j.pain.0000000000002036. https://pubmed.ncbi.nlm.nih.gov/32826751/ Dyspareunia, also known as vaginal hyperalgesia, is a prevalent and debilitating symptom of gynaecological disorders such as endometriosis and vulvodynia. Despite this, the sensory pathways transmitting nociceptive information from female reproductive organs remain poorly characterised. As such, the development of specific treatments for pain associated with dyspareunia is currently lacking. Here, we examined, for the first time, (1) the mechanosensory properties of pelvic afferent nerves innervating the mouse vagina; (2) the expression profile of voltage-gated sodium (NaV) channels within these afferents; and (3) how pharmacological modulation of these channels alters vaginal nociceptive signalling ex vivo, in vitro, and in vivo. We developed a novel afferent recording preparation and characterised responses of pelvic afferents innervating the mouse vagina to different mechanical stimuli. Single-cell reverse transcription-polymerase chain reaction determined mRNA expression of NaV channels within vagina-innervating dorsal root ganglia neurons. Vagina-innervating dorsal root ganglia neuroexcitability was measured using whole-cell patch-clamp electrophysiology. Nociception evoked by vaginal distension was assessed by dorsal horn neuron activation within the spinal cord and quantification of visceromotor responses. We found that pelvic afferents innervating the vagina are tuned to detect various mechanical stimuli, with NaV channels abundantly expressed within these neurons.
    [Show full text]
  • Lichen Sclerosus Complicated by Vaginal Stenosis: Diagnosis and Management
    CASE REPORT Lichen Sclerosus Complicated by Vaginal Stenosis: Diagnosis and Management Seyfettin ULUDA⁄1, Cem MAT2, Altay GEZER1, Arife fi‹MfiEK1, Tar›k ALTINOK1 1Department of Obstetrics and Gynecology, Cerrahpafla Medical Faculty, ‹stanbul University, ‹stanbul, Turkey 2Department of Dermatology, Cerrahpafla Medical Faculty, ‹stanbul University, ‹stanbul, Turkey Received 08 November 2007; received in revised form 23 December 2007; accepted 23 May 2008; published online 01 September 2008 Abstract Lichen sclerosus is a chronic, skin disease. The involvement of the vagina is not a characteristic of lichen sclerosus. We report a rare case of vulvovaginal syndrome as a complication of lichen sclerosus with the diagnosis and the management of vaginal synechia leading to intravaginal fluid accumulation mimicking pelvic mass. There were two interesting aspects of this case. First, the location of the synechia was behind the introitus, in the vagina. The second was the presence of a pelvic cyst in the lower pelvis. The surgical correction of the case was accomplished with vulvoperninoplasty but the difficulty of this procedure was the identification of the vaginal mucosa after dissection of the synechia. On the next step, the mucosa was attached to the vulvar skin with separate sutures. The postsurgical corticosteroid treatment and the regular dilatation of the introitus are essential to prevent the restenosis. Keywords: lichen sclerosus, vaginal synechia, vaginoperineoplasty Özet Vajinal Stenozla Komplike Liken Sklerozus: Tan› ve Tedavi Liken sklerozus kronik bir deri hastal›¤›d›r. Vajina tutulumu liken sklerozusta ender olarak görülür. Liken sklerozusa ba¤l› oluflan, vajina ve gerisinde pelvik kitleyi taklit eden bir vajinal sinefli olgusu sunularak tan› ve tedavisi tart›fl›lm›flt›r.
    [Show full text]